Pub Date : 2024-11-06DOI: 10.3760/cma.j.cn112150-20240830-00693
L Liu, J L Zhang, W T Luo, A L Li, B Q Sun
Wheat and buckwheat allergies are common food allergies that significantly impact patients' quality of life and health. Wheat allergy encompasses various forms, including wheat food allergy, exercise-induced allergic reactions (WDEIA), baker's occupational asthma/allergy, and contact urticaria. IgE-mediated allergic reactions involve sensitization to stable wheat allergens such as ω-5 gliadin and gluten. Although buckwheat allergy is less common, it is gaining attention in certain regions. Allergen component diagnostic technologies, by detecting specific allergen components [e.g., ω-5 gliadin, gliadins (α, β, γ), and Tri a 14], offer precise allergen source identification, aiding in the optimization of diagnosis and management processes. Oral challenge tests are considered the gold standard for diagnosing wheat allergy, and combining skin prick tests with specific IgE measurements can enhance diagnostic accuracy. While avoidance of allergens remains the primary management strategy, research into immunotherapy is ongoing. Future research should focus on a deeper understanding of the structural and immunological characteristics of wheat and buckwheat allergens to develop more accurate diagnostic tools and treatment methods, thereby improving allergy management and patient quality of life. This article provides a detailed interpretation of the Molecular Allergology User's Guide 2.0 (MAUG 2.0) published by the European Academy of Allergy and Clinical Immunology (EAACI) and recent research advances on wheat and buckwheat allergies, highlighting the crucial role of allergen component diagnostics in optimizing food allergy diagnosis and treatment processes, supporting clinicians in accurately identifying common allergens and their cross-reactivity, and formulating more personalized treatment plans for patients.
小麦和荞麦过敏是常见的食物过敏,严重影响患者的生活质量和健康。小麦过敏有多种形式,包括小麦食物过敏、运动诱发过敏反应(WDEIA)、面包师职业性哮喘/过敏和接触性荨麻疹。IgE 介导的过敏反应涉及对稳定的小麦过敏原(如 ω-5 麦胶蛋白和麸质)的过敏。虽然荞麦过敏不太常见,但在某些地区正逐渐受到关注。过敏原成分诊断技术通过检测特定的过敏原成分[如ω-5麦胶蛋白、麦胶蛋白(α、β、γ)和Tri a 14],可精确识别过敏原来源,有助于优化诊断和管理流程。口服挑战试验被认为是诊断小麦过敏的黄金标准,将皮肤点刺试验与特异性 IgE 测量相结合可提高诊断的准确性。虽然避免接触过敏原仍是主要的治疗策略,但免疫疗法的研究仍在进行中。未来的研究应侧重于深入了解小麦和荞麦过敏原的结构和免疫学特征,以开发更准确的诊断工具和治疗方法,从而改善过敏管理和患者的生活质量。本文详细解读了欧洲过敏与临床免疫学学会(EAACI)发布的《分子过敏学用户指南 2.0》(MAUG 2.0)以及小麦和荞麦过敏的最新研究进展,强调了过敏原成分诊断在优化食物过敏诊断和治疗过程中的关键作用,支持临床医生准确识别常见过敏原及其交叉反应,为患者制定更加个性化的治疗方案。
{"title":"[Clinical diagnosis and management of wheat and buckwheat allergy: application and prospects of allergen component diagnostics].","authors":"L Liu, J L Zhang, W T Luo, A L Li, B Q Sun","doi":"10.3760/cma.j.cn112150-20240830-00693","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240830-00693","url":null,"abstract":"<p><p>Wheat and buckwheat allergies are common food allergies that significantly impact patients' quality of life and health. Wheat allergy encompasses various forms, including wheat food allergy, exercise-induced allergic reactions (WDEIA), baker's occupational asthma/allergy, and contact urticaria. IgE-mediated allergic reactions involve sensitization to stable wheat allergens such as ω-5 gliadin and gluten. Although buckwheat allergy is less common, it is gaining attention in certain regions. Allergen component diagnostic technologies, by detecting specific allergen components [e.g., ω-5 gliadin, gliadins (α, β, γ), and Tri a 14], offer precise allergen source identification, aiding in the optimization of diagnosis and management processes. Oral challenge tests are considered the gold standard for diagnosing wheat allergy, and combining skin prick tests with specific IgE measurements can enhance diagnostic accuracy. While avoidance of allergens remains the primary management strategy, research into immunotherapy is ongoing. Future research should focus on a deeper understanding of the structural and immunological characteristics of wheat and buckwheat allergens to develop more accurate diagnostic tools and treatment methods, thereby improving allergy management and patient quality of life. This article provides a detailed interpretation of the Molecular Allergology User's Guide 2.0 (MAUG 2.0) published by the European Academy of Allergy and Clinical Immunology (EAACI) and recent research advances on wheat and buckwheat allergies, highlighting the crucial role of allergen component diagnostics in optimizing food allergy diagnosis and treatment processes, supporting clinicians in accurately identifying common allergens and their cross-reactivity, and formulating more personalized treatment plans for patients.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"58 11","pages":"1797-1806"},"PeriodicalIF":0.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142629630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-06DOI: 10.3760/cma.j.cn112150-20240708-00547
Flow cytometry (FCM) is used to detect lymphocyte subsets and evaluate the level of cellular immunity in the body, which is one of the commonly used FCM detection projects in clinical practice. To date, numerous institutions and academic organizations, both domestically and internationally, have published guidelines and consensus documents covering various aspects, including the establishment of cytometry laboratories, standardized procedures for detecting lymphocyte subsets, and their clinical applications across different fields, each with a distinct focus. However, in clinical practice, laboratories continue to face challenges in establishing standardized quality management systems, implementing quality assurance activities, developing appropriate detection protocols and gating strategies for various scenarios, and identifying and resolving common issues encountered during detecting. Currently, there is no unified consensus on these issues. To standardize the development of quality management systems for lymphocyte subsets detecion via FCM, enhance laboratory quality management practices, and ensure the accuracy and reliability of results, the Laboratory Medicine Committee of Chinese Association of Integrative Medicine (LMC-CAIM) convened experts to formulate this expert consensus.
{"title":"[Consensus of experts on clinical quality management for flow cytometry-based detection of lymphocyte subsets].","authors":"","doi":"10.3760/cma.j.cn112150-20240708-00547","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240708-00547","url":null,"abstract":"<p><p>Flow cytometry (FCM) is used to detect lymphocyte subsets and evaluate the level of cellular immunity in the body, which is one of the commonly used FCM detection projects in clinical practice. To date, numerous institutions and academic organizations, both domestically and internationally, have published guidelines and consensus documents covering various aspects, including the establishment of cytometry laboratories, standardized procedures for detecting lymphocyte subsets, and their clinical applications across different fields, each with a distinct focus. However, in clinical practice, laboratories continue to face challenges in establishing standardized quality management systems, implementing quality assurance activities, developing appropriate detection protocols and gating strategies for various scenarios, and identifying and resolving common issues encountered during detecting. Currently, there is no unified consensus on these issues. To standardize the development of quality management systems for lymphocyte subsets detecion via FCM, enhance laboratory quality management practices, and ensure the accuracy and reliability of results, the Laboratory Medicine Committee of Chinese Association of Integrative Medicine (LMC-CAIM) convened experts to formulate this expert consensus.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"58 11","pages":"1641-1650"},"PeriodicalIF":0.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142629639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-06DOI: 10.3760/cma.j.cn112150-20240609-00457
S J Ma, K Chen, S Liu, T Y Lin, S S Zhang, H X Chen
Objective: To construct a signature for identifying active tuberculosis (TB) based on the relative expression orderings (REOs) of gene expression within a single sample. Methods: Using peripheral whole blood samples from 75 active TB and 69 latently infected individuals from four datasets as the training set, and highly stable REO patterns were extracted from the gene expression profile of the two groups of samples. Then, the gene pairs that reversed the REO pattern between the two groups were selected, and each gene pair was ranked in descending order based on their reversal degree. Finally, the top k gene pairs with the highest classification accuracy were selected as the signature for independent dataset validation. Results: A signature composed of seven gene pairs, denoted as 7-GPS, was constructed from the training set. The accuracy rate for 7-GPS to distinguish active TB from latently infected samples was 88.89%, and the accuracy rate for distinguishing active TB from normal samples was 90.09%. In the mixed validation data from different detection platforms, the AUC value for distinguishing active TB from latently infected samples was 0.914 (95%CI: 0.881-0.948), and the AUC value for distinguishing active TB from normal samples was 0.934 (95%CI: 0.904-0.964). In addition, the four genes ETV7, BATF2, ANKRD22 and CARD17P from this signature tended to be highly expressed in peripheral blood samples of active TB, and their expression values were significantly related to the duration of anti-tuberculosis treatment in clinical. Conclusion: The 7-GPS signature is robust and suitable for individualized analysis of a single peripheral blood sample. It has certain clinical application potential.
{"title":"[The construction of a peripheral blood qualitative transcriptional signature for the diagnosis of active tuberculosis].","authors":"S J Ma, K Chen, S Liu, T Y Lin, S S Zhang, H X Chen","doi":"10.3760/cma.j.cn112150-20240609-00457","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240609-00457","url":null,"abstract":"<p><p><b>Objective:</b> To construct a signature for identifying active tuberculosis (TB) based on the relative expression orderings (REOs) of gene expression within a single sample. <b>Methods:</b> Using peripheral whole blood samples from 75 active TB and 69 latently infected individuals from four datasets as the training set, and highly stable REO patterns were extracted from the gene expression profile of the two groups of samples. Then, the gene pairs that reversed the REO pattern between the two groups were selected, and each gene pair was ranked in descending order based on their reversal degree. Finally, the top <i>k</i> gene pairs with the highest classification accuracy were selected as the signature for independent dataset validation. <b>Results:</b> A signature composed of seven gene pairs, denoted as 7-GPS, was constructed from the training set. The accuracy rate for 7-GPS to distinguish active TB from latently infected samples was 88.89%, and the accuracy rate for distinguishing active TB from normal samples was 90.09%. In the mixed validation data from different detection platforms, the AUC value for distinguishing active TB from latently infected samples was 0.914 (95%<i>CI</i>: 0.881-0.948), and the AUC value for distinguishing active TB from normal samples was 0.934 (95%<i>CI</i>: 0.904-0.964). In addition, the four genes <i>ETV7</i>, <i>BATF2</i>, <i>ANKRD22</i> and <i>CARD17P</i> from this signature tended to be highly expressed in peripheral blood samples of active TB, and their expression values were significantly related to the duration of anti-tuberculosis treatment in clinical. <b>Conclusion:</b> The 7-GPS signature is robust and suitable for individualized analysis of a single peripheral blood sample. It has certain clinical application potential.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"58 11","pages":"1651-1658"},"PeriodicalIF":0.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142629741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-06DOI: 10.3760/cma.j.cn112150-20231121-00359
R Y Tan, F D Li, H Y Ma, J F Lin
To achieve early warning of dengue fever from multiple sources and improve the ability to detect and identify dengue fever outbreaks timely, we took Hangzhou as an example and proposed the possibility of early warning of dengue fever. This study divided early warning of dengue fever into three stages: early warning of epidemic source, epidemic symptom, and epidemic. The early warning of epidemic source and epidemic symptom were emphasized to provide reference for other similar studies. Our findings showed that the staged warning of dengue fever was meaningful. Combining the source early warning with the symptom early warning could improve the sensitivity of the warning. Monthly warning can be used as a supplement to weekly warning.
{"title":"[Construction and application of a staged early warning model for dengue fever].","authors":"R Y Tan, F D Li, H Y Ma, J F Lin","doi":"10.3760/cma.j.cn112150-20231121-00359","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20231121-00359","url":null,"abstract":"<p><p>To achieve early warning of dengue fever from multiple sources and improve the ability to detect and identify dengue fever outbreaks timely, we took Hangzhou as an example and proposed the possibility of early warning of dengue fever. This study divided early warning of dengue fever into three stages: early warning of epidemic source, epidemic symptom, and epidemic. The early warning of epidemic source and epidemic symptom were emphasized to provide reference for other similar studies. Our findings showed that the staged warning of dengue fever was meaningful. Combining the source early warning with the symptom early warning could improve the sensitivity of the warning. Monthly warning can be used as a supplement to weekly warning.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"58 11","pages":"1783-1788"},"PeriodicalIF":0.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142629605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-06DOI: 10.3760/cma.j.cn112150-20240229-00167
S M Zhong, Y C Tang, W X Zhang, Y Wu, H Li
Regular and adequate use of broad-spectrum sunscreen has been proven to offer significant protection against acute Ultraviolet-induced photodamage, photoaging, immunosuppression, and the development of skin tumors. However, concerns regarding the safety and standardized use of sunscreens persist, including potential allergenicity and irritability of certain organic sunscreens, the impact of systemic absorption on the endocrine system, the effect on vitamin D synthesis and absorption, and environmental implications. Special caution is advised when using small molecule organic sunscreens and nanoparticle inorganic sunscreens, especially for infants, pregnant women, and areas with damaged skin.
事实证明,定期、足量使用广谱防晒霜可有效防止紫外线引起的急性光损伤、光老化、免疫抑制和皮肤肿瘤的发生。然而,人们对防晒霜的安全性和标准化使用仍然存在担忧,包括某些有机防晒霜的潜在过敏性和刺激性、全身吸收对内分泌系统的影响、对维生素 D 合成和吸收的影响以及对环境的影响。建议在使用小分子有机防晒剂和纳米无机防晒剂时特别小心,尤其是婴儿、孕妇和皮肤受损部位。
{"title":"[The current state of sunscreen development and analysis of its scientific application and safety].","authors":"S M Zhong, Y C Tang, W X Zhang, Y Wu, H Li","doi":"10.3760/cma.j.cn112150-20240229-00167","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240229-00167","url":null,"abstract":"<p><p>Regular and adequate use of broad-spectrum sunscreen has been proven to offer significant protection against acute Ultraviolet-induced photodamage, photoaging, immunosuppression, and the development of skin tumors. However, concerns regarding the safety and standardized use of sunscreens persist, including potential allergenicity and irritability of certain organic sunscreens, the impact of systemic absorption on the endocrine system, the effect on vitamin D synthesis and absorption, and environmental implications. Special caution is advised when using small molecule organic sunscreens and nanoparticle inorganic sunscreens, especially for infants, pregnant women, and areas with damaged skin.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"58 11","pages":"1771-1776"},"PeriodicalIF":0.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142629742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-06DOI: 10.3760/cma.j.cn112150-20240617-00478
C Y Qu, F Zhang, X H Yuan, L H Cai, B Li, X H Zhang
<p><p>To investigate the levels and clinical significance of serum microRNA (<i>miR</i>)<i>-146a</i>, <i>miR-145</i>, T-helpertype17 (Th17)/regulatory T cell (Treg) in children with respiratory syncytial virus (RSV) infectious pneumonia. The clinical data of 200 children with RSV infectious pneumonia admitted to Nantong Maternal and Child Health Hospital from June 2020 to June 2023 were retrospectively collected as the study group. At the same time, 200 children with mycoplasma pneumonia were selected as the common pneumonia group and 200 healthy children were selected as the healthy group. The levels of serum inflammatory factors [interleukin-6 (IL-6), interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α)] were detected by enzyme-linked immunosorbent assay. The expression levels of serum <i>miR-146a</i> and <i>miR-145</i> were detected by RT-qPCR. The levels of Th17/Treg were detected by flow cytometry. The levels of <i>miR-146a</i>, <i>miR-145</i>, Th17/Treg and serum inflammatory factors were compared among the three groups. Pearson method was used to analyze the correlation between <i>miR-146a</i>, <i>miR-145</i>, Th17/Treg and serum inflammatory factors in children with RSV infectious pneumonia. The receiver operating characteristic (ROC) curve was drawn to analyze the diagnostic value of <i>miR-146a</i>, <i>miR-145</i>, Th17/Treg in children with respiratory syncytial virus infection pneumonia. The results showed that in the study group, <i>miR-146a</i> (2.01±0.58), <i>miR-145</i> (1.81±0.46), Th17/Treg (1.09±0.31), IL-6 (7.82±2.11) ng/L and TNF-α (9.82±2.96) ng/L were higher than those in the common pneumonia group <i>miR-146a</i> (1.49±0.42), <i>miR-145</i> (1.43±0.31), Th17/Treg (0.77±0.24), IL-6 (5.89±1.32) ng/L, TNF-α (7.34±2.32) ng/L and healthy group <i>miR-146a</i> (1.25±0.19), <i>miR-145</i> (1.19±0.16), Th17/Treg (0.38±0.09), IL-6 (4.52±1.04) ng/L, TNF-α (5.39±1.07)ng/L. The levels of the above indexes in the common pneumonia group were higher than those in the healthy group, and the differences were statistically significant (<i>F</i>=183.543, 175.938, 617.182, 226.657, 193.459, <i>P</i><0.05). In the study group, IFN-γ (14.18±3.25) pg/ml was lower than that in the control group (19.52±5.13) pg/ml, but higher than that in the healthy group (9.77±2.40) pg/ml, and the difference was statistically significant (<i>F</i>=335.432, <i>P</i><0.05). Pearson correlation analysis showed that <i>miR-146a</i>, <i>miR-145</i> and Th17/Treg were positively correlated with IL-6 and TNF-α (<i>P</i><0.05), but negatively correlated with IFN-γ (<i>P</i><0.05). ROC curve results showed that the area under the curve (AUC) of <i>miR-146a</i>, <i>miR-145</i> and Th17/Treg in the diagnosis of RSV infectious pneumonia was 0.767, 0.762 and 0.790, respectively, while the combined detection of the three was 0.904. In conclusion, the levels of <i>miR-146a</i>, <i>miR-145</i> and Th17/Treg are highly expressed in children with RSV infectious pneumonia, and ar
{"title":"[The levels and clinical significance of serum <i>miR-146a, miR-145</i>, Th17/Treg in children with respiratory syncytial virus infection pneumonia].","authors":"C Y Qu, F Zhang, X H Yuan, L H Cai, B Li, X H Zhang","doi":"10.3760/cma.j.cn112150-20240617-00478","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240617-00478","url":null,"abstract":"<p><p>To investigate the levels and clinical significance of serum microRNA (<i>miR</i>)<i>-146a</i>, <i>miR-145</i>, T-helpertype17 (Th17)/regulatory T cell (Treg) in children with respiratory syncytial virus (RSV) infectious pneumonia. The clinical data of 200 children with RSV infectious pneumonia admitted to Nantong Maternal and Child Health Hospital from June 2020 to June 2023 were retrospectively collected as the study group. At the same time, 200 children with mycoplasma pneumonia were selected as the common pneumonia group and 200 healthy children were selected as the healthy group. The levels of serum inflammatory factors [interleukin-6 (IL-6), interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α)] were detected by enzyme-linked immunosorbent assay. The expression levels of serum <i>miR-146a</i> and <i>miR-145</i> were detected by RT-qPCR. The levels of Th17/Treg were detected by flow cytometry. The levels of <i>miR-146a</i>, <i>miR-145</i>, Th17/Treg and serum inflammatory factors were compared among the three groups. Pearson method was used to analyze the correlation between <i>miR-146a</i>, <i>miR-145</i>, Th17/Treg and serum inflammatory factors in children with RSV infectious pneumonia. The receiver operating characteristic (ROC) curve was drawn to analyze the diagnostic value of <i>miR-146a</i>, <i>miR-145</i>, Th17/Treg in children with respiratory syncytial virus infection pneumonia. The results showed that in the study group, <i>miR-146a</i> (2.01±0.58), <i>miR-145</i> (1.81±0.46), Th17/Treg (1.09±0.31), IL-6 (7.82±2.11) ng/L and TNF-α (9.82±2.96) ng/L were higher than those in the common pneumonia group <i>miR-146a</i> (1.49±0.42), <i>miR-145</i> (1.43±0.31), Th17/Treg (0.77±0.24), IL-6 (5.89±1.32) ng/L, TNF-α (7.34±2.32) ng/L and healthy group <i>miR-146a</i> (1.25±0.19), <i>miR-145</i> (1.19±0.16), Th17/Treg (0.38±0.09), IL-6 (4.52±1.04) ng/L, TNF-α (5.39±1.07)ng/L. The levels of the above indexes in the common pneumonia group were higher than those in the healthy group, and the differences were statistically significant (<i>F</i>=183.543, 175.938, 617.182, 226.657, 193.459, <i>P</i><0.05). In the study group, IFN-γ (14.18±3.25) pg/ml was lower than that in the control group (19.52±5.13) pg/ml, but higher than that in the healthy group (9.77±2.40) pg/ml, and the difference was statistically significant (<i>F</i>=335.432, <i>P</i><0.05). Pearson correlation analysis showed that <i>miR-146a</i>, <i>miR-145</i> and Th17/Treg were positively correlated with IL-6 and TNF-α (<i>P</i><0.05), but negatively correlated with IFN-γ (<i>P</i><0.05). ROC curve results showed that the area under the curve (AUC) of <i>miR-146a</i>, <i>miR-145</i> and Th17/Treg in the diagnosis of RSV infectious pneumonia was 0.767, 0.762 and 0.790, respectively, while the combined detection of the three was 0.904. In conclusion, the levels of <i>miR-146a</i>, <i>miR-145</i> and Th17/Treg are highly expressed in children with RSV infectious pneumonia, and ar","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"58 11","pages":"1733-1738"},"PeriodicalIF":0.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142629743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-06DOI: 10.3760/cma.j.cn112150-20240517-00400
Y H Ma, L S Shen, Y X Zheng
Colorectal cancer (CRC) represents a significant global health challenge as a common malignancy of the digestive tract. The involvement of B vitamins-specifically folic acid (B9), riboflavin (B2), pyridoxine (B6), and cobalamin (B12)-is crucial in metabolic processes by mediating the transfer of one-carbon (1C) units, which plays a fundamental role in cellular functions and tumor growth. 1C metabolism is involved in synthesis of proteins, lipids, nucleic acids, and other cofactors. 1C metabolism, intertwined with the metabolism of other nutrients, forms complex pathways where B vitamins act as precursors or coenzymes, influencing the production of various intermediates. These vitamins, as essential nutrients, are implicated to varying the pathogenesis and progression of colorectal cancer such as epigenetics. Furthermore, 1C metabolism affects tumor cell fate through multiple aspects including nucleotide synthesis, redox homeostasis, and the interaction with gut microbiota. Given these roles, understanding and monitoring B vitamin levels and their metabolic pathways are essential for colorectal cancer prevention and management. This approach not only helps in reducing tumor-related mortality but also opens new avenues for research into CRC mechanisms and potential therapeutic strategies.
结肠直肠癌(CRC)是消化道常见的恶性肿瘤,对全球健康构成重大挑战。B 族维生素,特别是叶酸(B9)、核黄素(B2)、吡哆醇(B6)和钴胺素(B12),通过介导一碳(1C)单位的转移,在新陈代谢过程中起着至关重要的作用。1C 代谢参与蛋白质、脂类、核酸和其他辅助因子的合成。1C 代谢与其他营养物质的代谢相互交织,形成了复杂的途径,其中 B 族维生素作为前体或辅酶,影响着各种中间产物的产生。这些维生素作为人体必需的营养素,与结直肠癌的发病机理和进展有关,如表观遗传学。此外,1C 代谢还通过核苷酸合成、氧化还原平衡以及与肠道微生物群的相互作用等多个方面影响肿瘤细胞的命运。鉴于这些作用,了解和监测 B 族维生素水平及其代谢途径对于结直肠癌的预防和管理至关重要。这种方法不仅有助于降低与肿瘤相关的死亡率,还为研究 CRC 机制和潜在治疗策略开辟了新途径。
{"title":"[Mechanisms and perspectives of B vitamins associated one carbon metabolism on colorectal cancer risk].","authors":"Y H Ma, L S Shen, Y X Zheng","doi":"10.3760/cma.j.cn112150-20240517-00400","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240517-00400","url":null,"abstract":"<p><p>Colorectal cancer (CRC) represents a significant global health challenge as a common malignancy of the digestive tract. The involvement of B vitamins-specifically folic acid (B9), riboflavin (B2), pyridoxine (B6), and cobalamin (B12)-is crucial in metabolic processes by mediating the transfer of one-carbon (1C) units, which plays a fundamental role in cellular functions and tumor growth. 1C metabolism is involved in synthesis of proteins, lipids, nucleic acids, and other cofactors. 1C metabolism, intertwined with the metabolism of other nutrients, forms complex pathways where B vitamins act as precursors or coenzymes, influencing the production of various intermediates. These vitamins, as essential nutrients, are implicated to varying the pathogenesis and progression of colorectal cancer such as epigenetics. Furthermore, 1C metabolism affects tumor cell fate through multiple aspects including nucleotide synthesis, redox homeostasis, and the interaction with gut microbiota. Given these roles, understanding and monitoring B vitamin levels and their metabolic pathways are essential for colorectal cancer prevention and management. This approach not only helps in reducing tumor-related mortality but also opens new avenues for research into CRC mechanisms and potential therapeutic strategies.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"58 11","pages":"1739-1751"},"PeriodicalIF":0.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142629699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-06DOI: 10.3760/cma.j.cn112150-20231207-00414
H X Zhang, F Jiang, H Li, X Q Wang, X T Liu, Y L Wang, Z X Li, R X Li, W J Yang, C J Wang
Objective: To analyze the effect of birth parity on life expectancy (LE) and healthy life expectancy (HLE) among rural women. Method: A total of 15 304 women aged 40 to 79 years who participated in baseline and follow-up surveys were selected from a rural cohort in Henan province. The LE and HLE of women with different birth parity were calculated by using multi-state life table. Results: There were 1 195 (7.8%), 7 782 (50.8%), 3 867 (25.3%) and 2 460 (16.1%) women with 1, 2, 3 and 4 birth parities, respectively, and the M (Q1 and Q3) of age were 50.3 (47.3, 53.4) and 53.3 (48.8, 60.7), 62.6 (55.4, 66.9) and 69.5 (64.7, 73.4) years old, respectively. LE at 40 years old was 44.5, 44.8, 45.1 and 45.4 years old, and HLE was 17.7, 18.3, 18.8 and 19.3 years old, respectively. LE at age 40 increased by 0.3, 0.6, and 0.9 years in women with 2, 3, and 4 birth parities or more and HLE increased by 0.5, 1.1, and 1.6 years, respectively, compared with women with 1 birth parity. For women with higher and lower socioeconomic status who had 4 birth parities or more, the LE at age 40 was 47.1 and 43.9 years, respectively, an increase of 0.2 and 0.1 years over women with 1 birth parity, respectively; and the HLE was 20.4 and 18.7 years, respectively, an increase of 1.4 and 1.3 years over women with 1 birth parity, respectively. Conclusion: LE and HLE show an upward trend with the increase of birth parity among rural women.
{"title":"[Effect of birth parity on life expectancy and healthy life expectancy among rural women].","authors":"H X Zhang, F Jiang, H Li, X Q Wang, X T Liu, Y L Wang, Z X Li, R X Li, W J Yang, C J Wang","doi":"10.3760/cma.j.cn112150-20231207-00414","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20231207-00414","url":null,"abstract":"<p><p><b>Objective:</b> To analyze the effect of birth parity on life expectancy (LE) and healthy life expectancy (HLE) among rural women. <b>Method:</b> A total of 15 304 women aged 40 to 79 years who participated in baseline and follow-up surveys were selected from a rural cohort in Henan province. The LE and HLE of women with different birth parity were calculated by using multi-state life table. <b>Results:</b> There were 1 195 (7.8%), 7 782 (50.8%), 3 867 (25.3%) and 2 460 (16.1%) women with 1, 2, 3 and 4 birth parities, respectively, and the <i>M</i> (<i>Q</i><sub>1</sub> and <i>Q</i><sub>3</sub>) of age were 50.3 (47.3, 53.4) and 53.3 (48.8, 60.7), 62.6 (55.4, 66.9) and 69.5 (64.7, 73.4) years old, respectively. LE at 40 years old was 44.5, 44.8, 45.1 and 45.4 years old, and HLE was 17.7, 18.3, 18.8 and 19.3 years old, respectively. LE at age 40 increased by 0.3, 0.6, and 0.9 years in women with 2, 3, and 4 birth parities or more and HLE increased by 0.5, 1.1, and 1.6 years, respectively, compared with women with 1 birth parity. For women with higher and lower socioeconomic status who had 4 birth parities or more, the LE at age 40 was 47.1 and 43.9 years, respectively, an increase of 0.2 and 0.1 years over women with 1 birth parity, respectively; and the HLE was 20.4 and 18.7 years, respectively, an increase of 1.4 and 1.3 years over women with 1 birth parity, respectively. <b>Conclusion:</b> LE and HLE show an upward trend with the increase of birth parity among rural women.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"58 11","pages":"1684-1689"},"PeriodicalIF":0.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142629674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-06DOI: 10.3760/cma.j.cn112150-20240805-00625
Y Zong
Autoimmune gastritis (AIG) is a special type of atrophic gastritis caused by autoimmune abnormalities. Diagnosis of AIG is often delayed because of the absence of typical symptoms in the early stage, which results in inadequate treatment and poor cancer screening. It is crucial to improve the awareness of this disease. This article summarizes the clinical manifestations, endoscopic features, and treatments of autoimmune gastritis. Conventional therapy consists of adequate iron and vitamin B12 supplementation as well as symptomatic approaches. The associated risk for gastric adenocarcinoma and gastric neuroendocrine tumors requires regular endoscopic follow up. This article is helpful in prevention and treatment of AIG.
{"title":"[Update on diagnosis and treatment in autoimmune gastritis].","authors":"Y Zong","doi":"10.3760/cma.j.cn112150-20240805-00625","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240805-00625","url":null,"abstract":"<p><p>Autoimmune gastritis (AIG) is a special type of atrophic gastritis caused by autoimmune abnormalities. Diagnosis of AIG is often delayed because of the absence of typical symptoms in the early stage, which results in inadequate treatment and poor cancer screening. It is crucial to improve the awareness of this disease. This article summarizes the clinical manifestations, endoscopic features, and treatments of autoimmune gastritis. Conventional therapy consists of adequate iron and vitamin B12 supplementation as well as symptomatic approaches. The associated risk for gastric adenocarcinoma and gastric neuroendocrine tumors requires regular endoscopic follow up. This article is helpful in prevention and treatment of AIG.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"58 11","pages":"1752-1757"},"PeriodicalIF":0.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142629746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-06DOI: 10.3760/cma.j.cn112150-20231219-00462
J Q Zhan, L L Song, Y Lin, Y Dong, Y Wang, W Chu
<p><p><b>Objective:</b> To investigate and analyze the correlation between the expression levels of CD38, HLA-DR and programmed cell death-1 (PD-1) on peripheral blood CD8<sup>+</sup>T cells and HIV-1 RNA viral load, immune activation and exhaustion in patients with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS). <b>Methods:</b> A total of 81 HIV/AIDS patients (64 without antiretroviral therapy and 17 with therapy) and 40 healthy donors in the same period were enrolled as the control group. Flow cytometry was used to analyze the CD4<sup>+</sup>T lymphocyte count and the expression levels of activation markers CD38 and HLA-DR and apoptosis marker PD-1 on CD8<sup>+</sup>T cells. HIV-1 RNA in the plasma of HIV-1 infected patients was quantitatively detected by real-time fluorescence quantitative polymerase chain reaction. Variance analysis was used to compare the expression levels of CD38, HLA-DR and PD-1 on CD8<sup>+</sup>T cells between HIV/AIDS patients and healthy controls. Spearman correlation analysis was used to analyze the correlation between different T lymphocyte counts and HIV RNA viral load, and the correlation between HIV RNA viral load and peripheral blood CD8<sup>+</sup>T cell CD38, HLA-DR and PD-1. <b>Results:</b> Among the 81 HIV/AIDS patients, 69 (85.19%) were males and 12 (14.81%) were females, with an age <i>M</i> (<i>Q</i><sub>1</sub><i>, Q</i><sub>3</sub>) of 58 (36.5, 65.0) years. There were 60 HIV/AIDS patients over 55 years old (74.07%) and 21 HIV/AIDS patients between 18 and 55 years old (25.93%). The results of variance analysis showed that compared with the healthy control group, the expression levels of CD38, HLA-DR and PD-1 on CD8<sup>+</sup>T cells in HIV/AIDS patients increased, and the differences were statistically significant (all <i>P</i><0.05). In addition, the expression of CD38, HLA-DR and PD-1 increased significantly in patients with CD4<sup>+</sup>T cell count less than 350 cells/μl, and the differences were statistically significant (all <i>P</i><0.05). Spearman correlation analysis showed that CD4<sup>+</sup>and CD4<sup>+</sup>/CD8<sup>+</sup>were negatively correlated with viral load in HIV/AIDS patients (<i>r</i>=-0.407 and -0.378, respectively, both <i>P</i><0.05), and CD8<sup>+</sup>was positively correlated with viral load (<i>r</i>=0.356, <i>P</i><0.05). When the HIV RNA level was≤10<sup>5</sup> CPs/ml, there was no correlation between the HIV RNA level and the expression levels of CD38, HLA-DR and PD-1 on CD8<sup>+</sup>T cells (all <i>P</i>>0.05). However, when the level of HIV RNA was>10<sup>5</sup> CPs/ml, the level of HIV RNA was positively correlated with the expression levels of CD38, HLA-DR and PD-1 on CD8<sup>+</sup>T cells (<i>r</i>=0.412, 0.387, 0.395, respectively, all <i>P</i><0.05). <b>Conclusions:</b> The activation levels of CD38 and HLA-DR and the expression of PD-1 on CD8<sup>+</sup>T cells in the peripheral blood of HIV/AIDS patients are increased. When
{"title":"[Study on the correlation between viral load and activation and exhaustion levels of CD8<sup>+</sup>T cells in HIV/AIDS patients].","authors":"J Q Zhan, L L Song, Y Lin, Y Dong, Y Wang, W Chu","doi":"10.3760/cma.j.cn112150-20231219-00462","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20231219-00462","url":null,"abstract":"<p><p><b>Objective:</b> To investigate and analyze the correlation between the expression levels of CD38, HLA-DR and programmed cell death-1 (PD-1) on peripheral blood CD8<sup>+</sup>T cells and HIV-1 RNA viral load, immune activation and exhaustion in patients with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS). <b>Methods:</b> A total of 81 HIV/AIDS patients (64 without antiretroviral therapy and 17 with therapy) and 40 healthy donors in the same period were enrolled as the control group. Flow cytometry was used to analyze the CD4<sup>+</sup>T lymphocyte count and the expression levels of activation markers CD38 and HLA-DR and apoptosis marker PD-1 on CD8<sup>+</sup>T cells. HIV-1 RNA in the plasma of HIV-1 infected patients was quantitatively detected by real-time fluorescence quantitative polymerase chain reaction. Variance analysis was used to compare the expression levels of CD38, HLA-DR and PD-1 on CD8<sup>+</sup>T cells between HIV/AIDS patients and healthy controls. Spearman correlation analysis was used to analyze the correlation between different T lymphocyte counts and HIV RNA viral load, and the correlation between HIV RNA viral load and peripheral blood CD8<sup>+</sup>T cell CD38, HLA-DR and PD-1. <b>Results:</b> Among the 81 HIV/AIDS patients, 69 (85.19%) were males and 12 (14.81%) were females, with an age <i>M</i> (<i>Q</i><sub>1</sub><i>, Q</i><sub>3</sub>) of 58 (36.5, 65.0) years. There were 60 HIV/AIDS patients over 55 years old (74.07%) and 21 HIV/AIDS patients between 18 and 55 years old (25.93%). The results of variance analysis showed that compared with the healthy control group, the expression levels of CD38, HLA-DR and PD-1 on CD8<sup>+</sup>T cells in HIV/AIDS patients increased, and the differences were statistically significant (all <i>P</i><0.05). In addition, the expression of CD38, HLA-DR and PD-1 increased significantly in patients with CD4<sup>+</sup>T cell count less than 350 cells/μl, and the differences were statistically significant (all <i>P</i><0.05). Spearman correlation analysis showed that CD4<sup>+</sup>and CD4<sup>+</sup>/CD8<sup>+</sup>were negatively correlated with viral load in HIV/AIDS patients (<i>r</i>=-0.407 and -0.378, respectively, both <i>P</i><0.05), and CD8<sup>+</sup>was positively correlated with viral load (<i>r</i>=0.356, <i>P</i><0.05). When the HIV RNA level was≤10<sup>5</sup> CPs/ml, there was no correlation between the HIV RNA level and the expression levels of CD38, HLA-DR and PD-1 on CD8<sup>+</sup>T cells (all <i>P</i>>0.05). However, when the level of HIV RNA was>10<sup>5</sup> CPs/ml, the level of HIV RNA was positively correlated with the expression levels of CD38, HLA-DR and PD-1 on CD8<sup>+</sup>T cells (<i>r</i>=0.412, 0.387, 0.395, respectively, all <i>P</i><0.05). <b>Conclusions:</b> The activation levels of CD38 and HLA-DR and the expression of PD-1 on CD8<sup>+</sup>T cells in the peripheral blood of HIV/AIDS patients are increased. When","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"58 11","pages":"1690-1696"},"PeriodicalIF":0.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142629708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}